6-K ·Filed Sep 2, 2026

QTEX

QTREX Quantum Ltd.
BULLISH
Impact 7/10
Horizonweeks Processed1mo ago SEC0001185185-26-003806
Notable filing: 6-K
Actionable Insight ▲ Bullish

This is a high-impact validation event for QTREX's AME technology, but the stock's history of dilutive financing and going concern risk means traders should watch for follow-on definitive agreements and any further equity raises. The cross-filing context of a recent dilutive offering and a going concern qualification creates a binary outcome: if the defense program converts to a multi-system procurement, the revenue potential could transform the company; if not, the dilutive overhang and cash burn remain dominant risks.

DirectionBullish
Confidencemedium
Horizonweeks
Latest settled — T+20d
QTEX ▼ -16.42% at T+20d
LONG call ✗ call lost -16.42% · α vs SPY -16.34% · entry $0.8160 → $0.6820
Next anchor: T+60d in 8w
Entry anchored
Sep 2, 08:39 AM ET
via 1-min bar
T+1d
+0.25%
call +0.25% · α -0.80%
$0.8180
settled 4w ago
T+5d
+0.29%
call +0.29% · α +1.25%
$0.8184
settled 23d ago
T+20d
-16.42%
call -16.42% · α -16.34%
$0.6820
settled yesterday
T+60d
—
call — · α —
—
in 8w

Price Chart

Loading chart...

Executive Summary

QTREX Quantum announced that one of Israel's three largest defense companies has begun deploying its AME technology for a joint development program, with the first system now being installed. The agreement includes exclusivity provisions and outlines a potential phased commercial pathway with aggregate revenue in the tens of millions of dollars, though definitive agreements for subsequent phases have not been executed. This is a significant commercial validation for QTREX's AME platform, but the company faces a dilutive capital structure after a recent 19.6%-discounted offering and a going concern qualification on its 2025 financials, creating a high-risk, binary outcome profile.

Key Facts

  • One of Israel's three largest defense companies has begun deploying QTREX's AME technology, with the first system being installed at the partner's facilities.
  • The agreement includes exclusivity provisions and outlines a potential phased commercial pathway with aggregate revenue in the tens of millions of dollars.
  • Subsequent phases are subject to negotiation and execution of definitive agreements.
  • The partner's identity is not disclosed due to contractual confidentiality obligations.
  • This follows a dilutive offering on August 21, 2026, of 11,111,111 shares at $0.90 per share (19.6% discount), raising ~$9.1 million.
  • The company had a going concern qualification on its 2025 annual report (20-F).

Financial Impact

Potential aggregate revenue in the tens of millions of dollars from the phased commercial pathway, but no definitive agreements for subsequent phases have been executed.

revenue

Risk Factors

  • No definitive agreements for subsequent phases have been executed, creating execution risk.
  • The company has a history of dilutive equity offerings (four in 2026) and a going concern qualification, indicating cash constraints.
  • The partner's identity is undisclosed, limiting the ability to independently verify the program's scope and credibility.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001185185-26-003806
Document: qtrexex99-1.htm0001185185-26-003806
Document: 0001185185-26-003806-index-headers.html0001185185-26-003806
Document: 0001185185-26-003806-index.html0001185185-26-003806
Document: 0001185185-26-003806.txt0001185185-26-003806
19 reports for QTEX
Performance horizon
60% Hit rate 3 of 5 directional calls best @ T+60▲ +53.16%Jun 17, 2026
Filters
Rows
Reports for QTEX — sortable, filterable
TypeNow
Sep 2, 2026
4w ago
6-K
BULLISH ★ 7/10
$0.8160 $0.6820▼ −16.42%▼ −16.34%$1.10 (+34.80%)
Aug 21, 2026
6w ago
424B5
BEARISH ★ 6/10
$0.9155 $0.8564▲ +6.46%▲ +5.93%$1.10 (−20.15%)
Aug 19, 2026
6w ago
6-K
NEUTRAL ★ 4/10
$1.12 $0.8702▼ −22.30%▼ −20.35%$1.10 (−1.79%)
Aug 3, 2026
8w ago
6-K
NEUTRAL ★ 4/10
$1.01 $0.8273▼ −18.09%▼ −19.33%$1.10 (+8.91%)
Jul 31, 2026
9w ago
Press Release
NEUTRAL ★ 4/10
$0.9000 $0.8340▼ −7.33%▼ −10.32%$1.10 (+22.22%)
Jul 24, 2026
10w ago
6-K
NEUTRAL ★ 5/10
$0.9497 $0.8664▼ −8.77%▼ −12.07%$1.10 (+15.83%)
Jul 22, 2026
10w ago
Press Release
MIXED ★ 5/10
$0.9060 $1.12▲ +23.62%▲ +20.72%$1.10 (+21.41%)
Jul 17, 2026
11w ago
6-K
NEUTRAL ★ 2/10
$1.27 $0.9799▼ −22.84%▼ −27.29%$1.10 (−13.39%)
Jul 17, 2026
11w ago
Press Release
NEUTRAL ★ 2/10
$1.27 $0.9799▼ −22.84%▼ −27.29%$1.10 (−13.39%)
Jul 14, 2026
11w ago
6-K
BULLISH ★ 5/10
$1.50 $0.9959▼ −33.61%▼ −36.10%$1.10 (−26.67%)
Showing 10 of 19

US Market Status

Market Closed — Opens Mon (56h 23m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access